Item 4.01 Changes in Registrant's Certifying Accountant

(b) On April 19, 2023, Avenir Wellness Solutions, Inc. (the "Company"), a Delaware corporation formerly known as CURE Pharmaceutical Holding Corp., engaged Urish Popeck, & Co. (the "New Auditor"), as the Company's independent registered public accounting firm, effective April 19, 2023, for the audit of the Company's financials for the fiscal year ended December 31, 2022. The decision to engage the New Auditor as the Company's independent registered public accounting firm was approved by the Company's Board of Directors and Audit Committee.

During the fiscal years ended December 31, 2022 and 2021, and the subsequent interim periods through the date of this Current Report on Form 8-K, neither the Company, nor anyone on its behalf, consulted the New Auditor regarding either:





    (1) the application of accounting principles to a specified transaction,
        either completed or proposed, or the type of audit opinion that might be
        rendered on the Company's financial statements, and no written report or
        oral advice was provided to the Company by the New Auditor that the New
        Auditor concluded was an important factor considered by the Company in
        reaching a decision as to any accounting, auditing or financial reporting
        issue; or

    (2) any matter that was the subject of a "disagreement" (as that term is
        defined in Item 304(a)(1)(iv) of Regulation S-K and the related
        instructions) or a "reportable event" (as that term is defined in Item
        304(a)(1)(v) of Regulation S-K).

© Edgar Online, source Glimpses